Genpact Ltd [G] stock is trading at $43.87, up 1.48%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The G shares have gain 4.35% over the last week, with a monthly amount drifted -8.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Genpact Ltd [NYSE: G] stock has seen the most recent analyst activity on February 07, 2025, when TD Cowen upgraded its rating to a Buy and also boosted its price target to $60 from $45. Previously, Jefferies upgraded its rating to Buy on January 21, 2025, and elevated its price target to $55. On July 17, 2024, upgrade upgraded it’s rating to Neutral and revised its price target to $40 on the stock. Mizuho started tracking the stock assigning a Neutral rating and suggested a price target of $40 on January 30, 2024. Robert W. Baird downgraded its rating to a Neutral but $38 remained the price target by the analyst firm on December 15, 2023. JP Morgan downgraded its rating to Underweight for this stock on August 22, 2023, but kept the price target unchanged to $40. In a note dated July 18, 2023, Citigroup downgraded an Neutral rating on this stock and revised its target price from $46 to $42.
Genpact Ltd [G] stock has fluctuated between $30.38 and $56.76 over the past year. Currently, Wall Street analysts expect the stock to reach $42.8 within the next 12 months. Genpact Ltd [NYSE: G] shares were valued at $43.87 at the most recent close of the market. An investor can expect a potential drop of -2.44% based on the average G price forecast.
Analyzing the G fundamentals
Genpact Ltd [NYSE:G] reported sales of 4.85B for the trailing twelve months, which represents a growth of 7.35%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.22 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.24 points at the first support level, and at 42.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 44.27, and for the 2nd resistance point, it is at 44.67.
Ratios To Look Out For
For context, Genpact Ltd’s Current Ratio is 2.45. Also, the Quick Ratio is 2.45, while the Cash Ratio stands at 0.71. Considering the valuation of this stock, the price to sales ratio is 1.58, the price to book ratio is 3.13 and price to earnings (TTM) ratio is 14.93.
Transactions by insiders
Recent insider trading involved Gangestad Nicholas C, Director, that happened on May 13 ’25 when 2000.0 shares were purchased. President and CEO, Kalra Balkrishan completed a deal on Mar 13 ’25 to sell 13600.0 shares. Meanwhile, Officer BALKRISHAN KALRA bought 13600.0 shares on Mar 13 ’25.
